Home
>
National Drug Code (NDC)
>
Viread
Viread - 24236-284-19 - (TENOFOVIR DISOPROXIL FUMARATE)
Drug Information of Viread
| Product NDC: | 24236-284 |
| Proprietary Name: | Viread |
| Non Proprietary Name: | TENOFOVIR DISOPROXIL FUMARATE |
| Active Ingredient(s): | 300 mg/1 & nbsp; TENOFOVIR DISOPROXIL FUMARATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Viread
| Product NDC: | 24236-284 |
| Labeler Name: | REMEDYREPACK INC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021356 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130328 |
Package Information of Viread
| Package NDC: | 24236-284-19 |
| Package Description: | 90 TABLET, COATED in 1 CANISTER (24236-284-19) |
NDC Information of Viread
| NDC Code | 24236-284-19 |
| Proprietary Name | Viread |
| Package Description | 90 TABLET, COATED in 1 CANISTER (24236-284-19) |
| Product NDC | 24236-284 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TENOFOVIR DISOPROXIL FUMARATE |
| Dosage Form Name | TABLET, COATED |
| Route Name | ORAL |
| Start Marketing Date | 20130328 |
| Marketing Category Name | NDA |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | TENOFOVIR DISOPROXIL FUMARATE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
